Carysil (524091) Aktienübersicht
Carysil Limited und seine Tochtergesellschaften produzieren und handeln in Indien mit Quarzküchen- und Edelstahlspülen, Badprodukten, Fliesen, Küchengeräten und Zubehör. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 1/6 |
| Künftiges Wachstum | 3/6 |
| Vergangene Leistung | 5/6 |
| Finanzielle Gesundheit | 6/6 |
| Dividenden | 3/6 |
Belohnungen
Risikoanalyse
Bei unseren Risikoprüfungen wurden keine Risiken für 524091 festgestellt.
524091 Community Fair Values
Create NarrativeSee what 14 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Carysil Limited Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | ₹1,173.00 |
| 52-Wochen-Hoch | ₹1,223.30 |
| 52-Wochen-Tief | ₹734.00 |
| Beta | 0.56 |
| 1 Monat Veränderung | 27.25% |
| 3 Monate Veränderung | 50.32% |
| 1 Jahr Veränderung | 28.20% |
| 3 Jahre Veränderung | 76.27% |
| 5 Jahre Veränderung | 105.52% |
| Veränderung seit IPO | 126,482.82% |
Aktuelle Nachrichten und Updates
524091: Subsidiary Simplification And Dividend Policy Will Support Future Upside
Carysil’s analyst price target is unchanged at ₹1,270.5, as analysts balance slightly adjusted assumptions for discount rate, revenue growth, profit margins and future P/E to arrive at the same fair value estimate. What's in the News A board meeting is scheduled for May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on the equity shares for FY 2025-26.524091: Subsidiary Rationalisation And QIP Extension Will Support Future Upside
Carysil’s analyst price target has changed from ₹1,205.67 to ₹1,270.50 as analysts incorporate slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a modestly higher fair value estimate. What's in the News A board meeting is scheduled on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider and recommend a final dividend, if any, on equity shares for the financial year ended March 31, 2026 (Key Developments).Recent updates
524091: Subsidiary Simplification And Dividend Policy Will Support Future Upside
Carysil’s analyst price target is unchanged at ₹1,270.5, as analysts balance slightly adjusted assumptions for discount rate, revenue growth, profit margins and future P/E to arrive at the same fair value estimate. What's in the News A board meeting is scheduled for May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider a final dividend on the equity shares for FY 2025-26.524091: Subsidiary Rationalisation And QIP Extension Will Support Future Upside
Carysil’s analyst price target has changed from ₹1,205.67 to ₹1,270.50 as analysts incorporate slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E, resulting in a modestly higher fair value estimate. What's in the News A board meeting is scheduled on May 20, 2026 to consider and approve audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and to consider and recommend a final dividend, if any, on equity shares for the financial year ended March 31, 2026 (Key Developments).524091: Subsidiary Rationalisation And QIP Timeline Extension Will Support Future Upside
Analysts have kept Carysil’s fair value estimate broadly unchanged at about ₹1,205.67, with only small tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions, leading to a steady overall price target narrative. What's in the News Board meeting scheduled on Mar 20, 2026 at 15:00 IST to review the appointment of an internal auditor and a cost auditor.524091: Subsidiary Closures And QIP Utilisation Decisions Will Support Future Upside
Analysts have kept their average price target for Carysil broadly steady at around ₹1,205.67, citing largely unchanged assumptions on revenue growth, profit margins and future P/E, with only minor adjustments to the discount rate in their models. What's in the News A board meeting is scheduled on Feb 04, 2026 to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (Key Developments).524091: Upcoming Board Decisions On Subsidiary Closures Will Support Future Upside
Analysts have kept their fair value estimate for Carysil steady at ₹1,205.67 per share, with only minimal tweaks to inputs such as the discount rate, revenue growth outlook, profit margin assumptions and future P/E. This reflects a view that recent data does not materially change the stock’s underlying valuation story.524091: Upcoming Board Results And Stable Assumptions Will Support Future Upside
Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, while making refinements to inputs such as a slightly lower discount rate and minor adjustments to revenue growth, profit margin, and future P/E expectations to reflect updated assumptions in their models. What's in the News Carysil has scheduled a board meeting for February 4, 2026 to review and approve unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).524091: Upcoming Results And Steady Assumptions Will Support Future Upside
Analysts have maintained their fair value estimate for Carysil at ₹1,205.67 per share, making only minor model adjustments, such as a slightly higher discount rate and a modestly higher assumed future P/E multiple. These changes together leave the overall price target unchanged.524091: Upcoming Results And Improved Margin Outlook Will Support Future Upside
Analysts have nudged their fair value estimate on Carysil higher from ₹1,165 to about ₹1,206, citing updated assumptions on discount rate, revenue growth, profit margins and future P/E that better reflect their current expectations for the business. What's in the News Carysil has scheduled a board meeting on February 4, 2026, to consider and approve its unaudited standalone financial results for the quarter and nine months ended December 31, 2025 (Key Developments).524091: Steady Outlook And Upcoming Results Date Will Support Future Upside
Analysts have kept their fair value estimate for Carysil steady at ₹1,165, with only marginal tweaks to inputs like the discount rate and assumed future P/E. This reflects fine tuning of their models rather than a change in their core view.524091: Steady Assumptions And Upcoming Results Will Support Future Upside
Analysts have maintained their price target for Carysil at ₹1,165 per share. This unchanged view mainly reflects consistent assumptions regarding fair value, discount rate, revenue growth, profit margin and future P/E.524091: Capacity Expansion Will Drive Future Earnings Momentum
Analysts have modestly raised their price target on Carysil to ₹1,165 per share (from ₹1,165), reflecting slightly higher discount rate and valuation assumptions while keeping long term growth and margin expectations broadly unchanged. What's in the News Carysil has scheduled a board meeting on November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).524091: Capacity Expansion And Dividend Increase Will Drive Upward Momentum
Analysts have raised their price target for Carysil from ₹1,130.33 to ₹1,165.00, citing improved forecasts for revenue growth and profit margins that support a higher fair value estimate. What's in the News A board meeting is scheduled for November 10, 2025 to consider and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).524091: New Capacity Expansion And Dividend Increase Set To Shape Outlook
Analysts have increased Carysil's fair value estimate from ₹1,039 to ₹1,130.33, citing modest changes in growth forecasts and profit margins, which support a slightly higher valuation target. What's in the News Carysil's board will meet on November 10, 2025, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (Board Meeting).Global Kitchen Upgrades And Market Expansion Will Transform Industry
Carysil’s consensus price target has been raised to ₹1039, reflecting a notable improvement in future earnings valuation as indicated by the decline in its forward P/E and a marginal uplift in expected revenue growth. What's in the News Board meeting scheduled to consider investment in a subsidiary company.
Partnerships With IKEA And Karran USA Will Drive Global Expansion In Kitchen Solutions
Carysil's global expansion and strategic partnerships in the U.S. are expected to significantly drive revenue growth and increase market presence.Aktionärsrenditen
| 524091 | IN Building | IN Markt | |
|---|---|---|---|
| 7D | 11.1% | 0.2% | 0.05% |
| 1Y | 28.2% | -8.0% | -2.0% |
Rendite im Vergleich zur Industrie: 524091 übertraf die Branche Indian Building , die im vergangenen Jahr eine Rendite von -8 erzielte.
Rendite vs. Markt: 524091 übertraf den Markt Indian, der im vergangenen Jahr eine Rendite von -2 erzielte.
Preisvolatilität
| 524091 volatility | |
|---|---|
| 524091 Average Weekly Movement | 7.2% |
| Building Industry Average Movement | 7.7% |
| Market Average Movement | 7.1% |
| 10% most volatile stocks in IN Market | 10.2% |
| 10% least volatile stocks in IN Market | 4.7% |
Stabiler Aktienkurs: 524091 hatte in den letzten 3 Monaten im Vergleich zum Indian -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: 524091Die wöchentliche Volatilität (7%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1987 | n/a | Chirag Parekh | www.carysil.com |
Carysil Limited produziert und vertreibt zusammen mit seinen Tochtergesellschaften in Indien Quarz- und Edelstahlspülen, Badprodukte, Fliesen, Küchengeräte und Zubehör. Das Unternehmen bietet Armaturen und Abfallbehälter, Küchenoberflächen, Designfliesen aus Quarz, Kücheneinbaugeräte wie Kamine, Kochplatten, Weinkühler, Geschirrspüler, Einbaubacköfen, Mikrowellen, Kochfelder, Herde, Eis- und Kaffeemaschinen und andere Produkte sowie Badprodukte wie Wasserklosetts, Armaturen und Wasserhähne an. Das Unternehmen vertreibt seine Produkte unter den Marken Tekcarysil, Carysil und Sternhagen.
Carysil Limited's Grundlagenzusammenfassung
| 524091 grundlegende Statistiken | |
|---|---|
| Marktanteil | ₹33.36b |
| Gewinn(TTM) | ₹981.90m |
| Umsatz(TTM) | ₹9.24b |
Ist 524091 zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| 524091 Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | ₹9.24b |
| Kosten der Einnahmen | ₹4.28b |
| Bruttogewinn | ₹4.96b |
| Sonstige Ausgaben | ₹3.97b |
| Gewinn | ₹981.90m |
Zuletzt gemeldete Gewinne
Mar 31, 2026
Datum des nächsten Gewinnberichts
k.A.
| Gewinn per Aktie (EPS) | 34.52 |
| Bruttomarge | 53.63% |
| Nettogewinnspanne | 10.63% |
| Schulden/Eigenkapital-Verhältnis | 43.9% |
Wie hat sich 524091 auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/06/15 19:37 |
| Aktienkurs zum Tagesende | 2026/06/15 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2026/03/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Carysil Limited wird von 7 Analysten beobachtet. 3 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Rishab Bothra | Anand Rathi Shares and Stock Brokers Limited |
| null null | Anand Rathi Shares and Stock Brokers Limited |
| Vyom Chheda | BP Wealth Management Private Limited |